Novo Nordisk A/S NVO is seeking FDA approval for the pill version of its obesity drug, Wegovy. The company recently highlighted early data that shows safety and efficacy figures that are similar t ...

Novo Nordisk remains the market leader in the U.S. with more than 50% market share measured by total monthly prescriptions. Please turn to the next slide. Wegovy sales increased by 39% in U.S ...

Ozempic grew by 18% while Wegovy grew by 85% compared to Q1 2024. It is mind-blowing to think that Novo Nordisk's current share price is close to the same level as in 2021 when Wegovy was just ...

Caremark negotiated an undisclosed lower net price for Wegovy over Zepbound on its standard formularies, offering savings on Novo Nordisk's drug to clients that opt into those plans. But ...